Advertise With Us
BioInsights Publishing Ltd

Bioconjugation Insights

Bioconjugation Insights is an online, open access, peer-reviewed journal with an interdisciplinary, translational focus on all aspects and areas of the bioconjugation field, including ADCs, oligonucleotide conjugates, protein and peptide conjugates, PEGylation, radioconjugates, conjugated vaccines, diagnostics, and more.

 

Bioconjugation Insights is designed to provide the understanding and need-to-know information required to navigate this rapidly advancing sector. It serves as the go-to online resource for the latest news, trends, challenges, and breakthroughs in bioconjugation.

Categories: Advertising, Arts & Entertainment, Biology, Books & Literature, Business, Science

Bionic ID: 691834

Advertising Options

Below are Bioconjugation Insights advertising placement options to consider in your media planning and media buying.

  • E-Newsletter Advertising

    • E-Newsletter
    • ETOC Alerts
    • Quarterly Newsletter
  • Magazine Advertising

    • 1/2 page - 1/2 page
    • 1/3 page - 1/3 page
    • 1/4 page - 1/4 page
    • 1/6 page - 1/6 page
    • Articles - Sponsorship
    • Full page - Full page
  • Other Advertising

    • Expert Roundtables - Sponsorship
    • Infographics - Sponsorship
    • Interviews - Sponsorship
    • Webinar
    • Webinars - Sponsorship
  • Podcast Advertising

    • Podcasts - Sponsorship
  • Social Advertising

    • Linkedin post
    • Twitter post
  • Video Advertising

    • On-Demand Video
    • Video
  • Online Display Advertising

    • 728x90 - Leaderboard - 728x90

Learn More

To learn more about the Bioconjugation Insights program, submit a request for information. Your request will be sent immediately to the BioInsights Publishing Ltd ad sales team.

Place an Order

To place an order, contact Bioconjugation Insights or order electronically through Bionic Media Buying Software using ID 691834.

© Copyright 2013-2022 NextMark, Inc. d/b/a Bionic Advertising Systems. All Rights Reserved. Terms of Use.